date,title,source
Oct-17-18,2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report,Motley Fool
Oct-19-18,"The Zacks Analyst Blog Highlights: AstraZeneca, salesforce, Mastercard, Lam Research and Koninklijke",Zacks
Oct-22-18,"Why Tesaro, Inc. Is Tanking Today",Motley Fool
Oct-22-18,Here's Why Clovis Oncology Dropped as Much as 21.2% Today,Motley Fool
Oct-22-18,AstraZeneca to Present New Data Demonstrating Breadth of Research Portfolio in Renal Disease at ASN Kidney Week 2018,Business Wire
Oct-23-18,[$$] AstraZeneca Adds Cancer Drugs to Pipeline,The Wall Street Journal
Oct-23-18,AstraZeneca digs deeper into cancer with Innate stake,Reuters
Oct-23-18,[$$] AstraZeneca deepens partnership with Innate Pharma,Financial Times
Oct-23-18,AstraZeneca to buy 9.8 percent stake in France's Innate Pharma,Reuters
Oct-24-18,Here's Why Tesaro Inc. Dropped 13.8% Today,Motley Fool
Oct-25-18,Today's Research Reports on Trending Tickers: AstraZeneca and Eli Lilly and Company,ACCESSWIRE
Oct-25-18,[$$] The London Report: dollar earners buoy FTSE 100,Financial Times
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,"Report: Exploring Fundamental Drivers Behind Manulife Financial, Baozun, AstraZeneca, Insight Enterprises, Albireo Pharma, and Mobile TeleSystems OJSC  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-30-18,"AstraZeneca sells some rights to Nexium, Vimovo to Grunenthal",Reuters
Oct-30-18,[$$] European Corporate Roundup,The Wall Street Journal
Oct-30-18,[$$] AstraZeneca to Sell Drugs Rights for $815M,The Wall Street Journal
Nov-01-18,European businesses demand urgent Brexit deal after meeting May,Reuters
Nov-01-18,The Landmark DECLARE-TIMI 58 Cardiovascular Outcomes Trial of FARXIGA in Patients with Type 2 Diabetes to Be Featured at AHA 2018,Business Wire
Nov-02-18,"Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus",Zacks
Nov-06-18,"Ionis Pharmaceuticals, Inc. (IONS) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-06-18,BMY vs. AZN: Which Stock Is the Better Value Option?,Zacks
Nov-06-18,"Cheplapharm Arzneimittel GmbH -- Moody's affirms Cheplapharm's B1 CFR, assigns B1 to term loan add-on, stable outlook",Moody's
Nov-06-18,Today's Research Reports on Trending Tickers: AbbVie and AstraZeneca,ACCESSWIRE
Nov-06-18,[$$] European Corporate Roundup,The Wall Street Journal
Nov-06-18,[$$] AstraZeneca sells trio of respiratory drugs for $350m,Financial Times
Nov-06-18,"AstraZeneca sells older asthma, rhinitis drugs for $350 million",Reuters
Nov-06-18,"AstraZeneca sells older asthma, rhinitis drugs for $350 mln",Reuters
Nov-07-18,Immunomedics Expands Clinical Collaboration With Astrazeneca to Include Metastatic Non-Small Cell Lung Cancer,GlobeNewswire
Nov-07-18,Astrazeneca Q3 Earnings Preview,Benzinga
Nov-08-18,AstraZeneca Breaks Out As CEO Predicts 'Sustained Growth' Streak,Investor's Business Daily
Nov-08-18,AstraZeneca lifts FTSE as U.S. midterm rally fades,Reuters
Nov-08-18,AstraZeneca chief says the US drugs market is under pressure and changes are coming,CNBC
Nov-08-18,AstraZeneca sees years of growth as drug sales turn corner,Reuters
Nov-08-18,"AstraZeneca's (AZN) Q3 Earnings Beat, New Drugs Drive Sales",Zacks
Nov-08-18,Astrazeneca: 3Q Earnings Snapshot,Associated Press
Nov-08-18,AstraZeneca sees years of growth as drug sales turn corner,Reuters
Nov-08-18,[$$] AstraZeneca 3Q Sales Increased on New Drug Performance,The Wall Street Journal
Nov-08-18,[$$] European Corporate Roundup,The Wall Street Journal
Nov-08-18,AstraZeneca has finally delivered its four-year objective...,CNBC Videos
Nov-08-18,"AstraZeneca returns to sales growth, led by cancer medicines",CNBC
Nov-08-18,"AstraZeneca returns to sales growth, led by cancer medicines",Reuters
Nov-08-18,[$$] AstraZeneca: back from the abyss,Financial Times
Nov-09-18,"Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug",Zacks
Nov-09-18,Today's Research Reports on Trending Tickers: AstraZeneca and Bristol-Myers Squibb,ACCESSWIRE
Nov-09-18,[$$] Opinion today: Europes plan for Donald Trump,Financial Times
Nov-12-18,"US FDA Accepts Regulatory Submission For LYNPARZA (olaparib) Maintenance Therapy in Newly-Diagnosed, BRCA-mutated Advanced Ovarian Cancer and Grants Priority Review",Business Wire
Nov-13-18,AstraZeneca's Lynparza Gets Priority Review in 1st Line Use,Zacks
Nov-13-18,This Recent Big Pharma Breakout Spiked Again On A $1.5 Billion Deal,Investor's Business Daily
Nov-13-18,$1.5B deal: AstraZeneca sells U.S. rights to respiratory medicine,American City Business Journals
Nov-13-18,AstraZeneca Keeps Pruning Drugs in $1.5 Billion Sale to Sobi,Bloomberg
Nov-13-18,[$$] European Corporate Roundup,The Wall Street Journal
Nov-13-18,Sobi buys rights to AstraZeneca infant drug for $1.5 bln upfront,Reuters
Nov-13-18,AstraZeneca sells infant drug rights to Sobi for $1.5 bln upfront,Reuters
Nov-14-18,AstraZeneca to Sell US Rights of Lung Infection Drug to Sobi,Zacks
Nov-14-18,"Tesaro, Clovis Rally on FDA Priority Review for Lynparza sNDA",Zacks
Nov-14-18,AstraZeneca (AZN): Are Hedge Funds Right to be Bearish?,Insider Monkey
Nov-16-18,Stocks Slide At Open; This Dow Jones Name Bucks Chip Sell Off,Investor's Business Daily
Nov-16-18,"Pharma Stock Roundup: FDA Updates on MRK, AZN's Cancer Drugs, Bayer's Q3 Earnings",Zacks
Nov-16-18,AstraZeneca Shows It Can Still Take Some Knocks,Bloomberg
Nov-16-18,Is AstraZeneca PLC (LON:AZN) Excessively Paying Its CEO?,Simply Wall St.
Nov-16-18,AstraZenecas Lung Cancer Trial Fails to Meet Main Goal,Bloomberg
Nov-16-18,[$$] AstraZeneca Mystic lung cancer trial fails to deliver results,Financial Times
Nov-19-18,Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta,Zacks
Nov-19-18,"AstraZeneca's Imfinzi Fails in Lung Cancer Study, Stock Down",Zacks
Nov-20-18,Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails,Zacks
Nov-20-18,Today's Research Reports on Trending Tickers: AstraZeneca and AbbVie,ACCESSWIRE
Nov-21-18,"Clovis' (CLVS) Rubraca Gets Another US Patent, Shares Up",Zacks
Nov-21-18,TESARO Shares Rally on Rumors of Potential Acquisition Offer,Zacks
Nov-21-18,Can Deal Interest Help Tesaro Recover?,Motley Fool
Nov-23-18,"Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs",Zacks
Nov-23-18,Read This Before You Buy AstraZeneca PLC (LON:AZN) Because Of Its P/E Ratio,Simply Wall St.
Nov-26-18,"The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca",Zacks
Nov-27-18,Astrazeneca's Fasenra Gets Orphan Drug for Autoimmune Disease,Zacks
Nov-27-18,AstraZeneca Presents Clinical Research Advances for Blood Cancer Patients at 2018 American Society of Hematology Annual Meeting,Business Wire
Nov-28-18,3 Top Dividend Stocks to Buy Right Now,Motley Fool
Nov-29-18,Biocartis partners with AstraZeneca on lung cancer diagnostics,Reuters
Nov-29-18,Biocartis partners with AstraZeneca on lung cancer diagnostics,Reuters
Nov-29-18,Biocartis Group NV: Biocartis and AstraZeneca Enter Into Agreement Aimed at Faster Lung Cancer Biomarker Results,GlobeNewswire
Nov-29-18,AstraZeneca PLC (LON:AZN): The Best Of Both Worlds,Simply Wall St.
Dec-03-18,New Long-Term Data on CALQUENCE Presented at ASH 2018,Business Wire
Dec-03-18,"[$$] Stocks to watch: GSK, RPC, Stobart, Ted Baker, Bodycote, Tesaro",Financial Times
Dec-04-18,"Glaxo to Buy Zejula Maker TESARO for $5.1B, Stock Down 8%",Zacks
Dec-04-18,TESARO Shares Rally on Glaxo's $5.1 Billion Buyout Offer,Zacks
Dec-07-18,New Biotech IPO Dropped a Unicorn-Sized Value on Its First Day,Bloomberg
Dec-07-18,AstraZeneca's Imfinzi fails to meet main goals in head and neck cancer study,Reuters
Dec-11-18,"Gabelli Names Clovis As Top Pick, Calls The Biotech A Likely Takeout Candidate",Benzinga
Dec-11-18,Moderna Stock Ushers In the Next Wave of Biotech,InvestorPlace
Dec-11-18,Can Moderna Stock Recover From Its Initial Setback?,Motley Fool
Dec-12-18,Here is What Hedge Funds Think About AstraZeneca plc (AZN),Insider Monkey
Dec-13-18,Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi,GlobeNewswire
Dec-13-18,Edited Transcript of AZN.L earnings conference call or presentation 26-Jul-18 11:30am GMT,Thomson Reuters StreetEvents
Dec-14-18,"Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus",Zacks
Dec-17-18,Merck to Acquire Europe's Antelliq Group for $2.4 Billion,Zacks
Dec-17-18,Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases,PR Newswire
Dec-18-18,Why a kidney disease drug approval in China is just the start for this S.F. company,American City Business Journals
Dec-18-18,[$$] Big Pharma Wins Drug Approval in China Ahead of West for First Time,The Wall Street Journal
Dec-18-18,BMY vs. AZN: Which Stock Should Value Investors Buy Now?,Zacks
Dec-18-18,"China first to approve AstraZeneca, FibroGen anaemia drug",Reuters
Dec-19-18,AstraZeneca's ovarian cancer drug gets FDA nod as maintenance treatment,Reuters
Dec-20-18,Can This Biotech Stock Rival Amgen In Anemia? Analyst Says Yes,Investor's Business Daily
Dec-20-18,[$$] Big Pharma Wins Drug Approval in China Ahead of West for First Time,The Wall Street Journal
Dec-20-18,AstraZeneca stock up 2.8% after announcing EU approval of COPD treatment,MarketWatch
Dec-20-18,Myriad Genetics' New FDA Nod for BRACAnalysis CDx Widens Base,Zacks
Dec-20-18,Phase III OLYMPUS and ROCKIES Trials for roxadustat Met Their Primary Endpoints in Chronic Kidney Disease Patients With Anemia,Business Wire
Dec-20-18,AstraZeneca's ovarian cancer and anaemia treatments meet goals in late-stage studies,Reuters
Dec-20-18,AstraZeneca's ovarian cancer and anemia treatments meet goals in late-stage studies,Reuters
Dec-20-18,[$$] Pharma Giants Plan Drug Price Hike: Report,The Wall Street Journal
Dec-21-18,"Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations",Zacks
Dec-24-18,"Health Care Digest: 'Killing off' the JPM Week golden goose, a $75 million complement and more",American City Business Journals
Dec-24-18,"The Zacks Analyst Blog Highlights: Procter & Gamble, Oracle, United Parcel Service, FedEx and AstraZeneca",Zacks
Dec-27-18,Immunomedics Enters Into Supply Deal for Breast Cancer Drug,Zacks
Dec-27-18,"Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019",Zacks
Jan-02-19,Could This New Biotech IPO Could Score Big With A Cancer Vaccine?,Investor's Business Daily
Jan-02-19,U.K. Manufacturers Step Up Stockpiling as Brexit Looms,Bloomberg
Jan-03-19,Why the Earnings Surprise Streak Could Continue for Astrazeneca (AZN),Zacks
Jan-04-19,"Ironwood co-founder, CEO will step down to head new spinout",American City Business Journals
Jan-04-19,Ironwood Pharmaceuticals Picks AstraZeneca Executive to Be Next CEO,The Wall Street Journal
Jan-04-19,"Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate",Zacks
Jan-07-19,AstraZeneca hires former Sloan Kettering specialist to lead oncology R&D unit,American City Business Journals
Jan-07-19,AstraZeneca picks Baselga to lead oncology R&D in growth plan,Reuters
Jan-07-19,"Ironwood to Get New CEO, Current CEO to Head Latest Spinoff",Zacks
Jan-07-19,AstraZeneca picks Baselga to lead oncology R&D in growth plan,Reuters
Jan-07-19,[$$] AstraZeneca Appoints Controversial Cancer Doctor to Head Research Unit,The Wall Street Journal
Jan-07-19,Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?,Zacks
Jan-07-19,AstraZeneca appoints Baselga to head R&D for oncology,Reuters
Jan-07-19,Sosei Heptares to Receive US$15 Million Milestone Payment From AstraZeneca With First Partnered Program Moving Towards Phase 2,PR Newswire
Jan-09-19,"Moderna (MRNA) Announces Pipeline Progress, Shares Rise",Zacks
Jan-10-19,"Astrazeneca lays off 210 as it closes drug manufacturing plants in Boulder, Longmont",American City Business Journals
Jan-10-19,Top Picks 2019- AstraZeneca PLC AZN,MoneyShow
Jan-14-19,Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe,Investor's Business Daily
Jan-14-19,House Democrats launch drug-pricing probe into a dozen major health-care companies,CNBC
Jan-14-19,Sell Amarin Stock on the Recent Takeover Rumors Rally,InvestorPlace
Jan-14-19,Can Inovio Pharmaceuticals Stock Keep Bounding Higher?,Motley Fool
Jan-14-19,What's in Store for Merck in 2019 After a Solid Run in '18?,Zacks
Jan-14-19,AstraZeneca Departures Continue as Medical Chief Bohen Exits,Bloomberg
Jan-15-19,BRIEF-Luye Pharma Announces Grant Of Promotion Right Of Xuezhikang Capsules In China To Astrazeneca,Reuters
Jan-16-19,Ironwood's (IRWD) Linzess Gets Approval in China for IBS-C,Zacks
Jan-16-19,"BRIEF-Luye Pharma Reaches Strategic Partnership With Astrazeneca, Strengthens Commitment To Cardiovascular Therapeutic Field",Reuters
Jan-17-19,NVS or AZN: Which Is the Better Value Stock Right Now?,Zacks
Jan-18-19,"Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY",Zacks
Jan-18-19,Immunomedics Gets CRL From FDA for Breast Cancer Candidate,Zacks
Jan-23-19,"The Daily Biotech Pulse: PTC Therapeutics, Select Biosciences Offering, Unity Biotech Expands Early-Stage Osteoporosis Drug Study",Benzinga
Jan-24-19,What's Behind the Biotech ETF Rally to Start 2019?,Zacks
Jan-24-19,Today's Research Reports on Trending Tickers: Teva Pharmaceutical Industries and AstraZeneca,ACCESSWIRE
Jan-28-19,Inovio's Early/Mid-Stage Vaccine Pipeline Exhibits Growth,Zacks
Jan-28-19,Why UPMC Health Plan reached Brilinta deal with big pharmaceutical company,American City Business Journals
Jan-28-19,"AstraZeneca, UPMC Health Plan sign risk-sharing deal for heart medicine",American City Business Journals
Jan-28-19,Merck (MRK) Q4 Earnings Coming Up: What's in the Cards?,Zacks
Jan-28-19,Clovis' Rubraca Gets Nod as Maintenance Therapy in Europe,Zacks
Jan-28-19,"Wallenberg Family Fortune Feels the Sting of Brexit, Trump",Bloomberg
Jan-29-19,New life science internship program launches to help boost diversity,American City Business Journals
Feb-01-19,Merck Pops On Quarterly Beat As Keytruda Sales Jump Despite U.S. Lag,Investor's Business Daily
Feb-01-19,Merck (MRK) Beats on Q4 Earnings &amp; Sales as Keytruda Shines,Zacks
Feb-04-19,Why Astrazeneca (AZN) Could Beat Earnings Estimates Again,Zacks
Feb-04-19,Alkermes Sinks as FDA Refuses to Approve Depression Drug,Zacks
Feb-05-19,Merck CEO Frazier to testify at Senate drug pricing hearing,Reuters
Feb-05-19,"Pharma execs will testify before Congress 'one way or another,' US senator says",CNBC
Feb-05-19,"AstraZeneca's infant respiratory drug prioritised in Europe, U.S.",Reuters
Feb-06-19,Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying,CNBC
Feb-08-19,"Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs",Zacks
Feb-13-19,Why Ironwood's Shares Climbed 11.7% on Wednesday,Motley Fool
Feb-14-19,"Why Marathon Oil, AstraZeneca, and Bloomin' Brands Jumped Today",Motley Fool
Feb-14-19,AstraZeneca Earnings Beat Views; Company Says It's 'Returned To Growth',Investor's Business Daily
Feb-14-19,FTSE 100 squeezes out gains; ConvaTec drags midcaps,Reuters
Feb-14-19,AstraZeneca Earnings: AZN Stock Zooms Higher on Q4 Beat,InvestorPlace
Feb-14-19,European shares give up three-month highs after shock U.S. data,Reuters
Feb-14-19,European shares give up 3-month highs after shock U.S. data,Reuters
Feb-14-19,AstraZeneca Earnings Beat Views; Company Says It's 'Returned To Growth',Investor's Business Daily
Feb-14-19,AstraZeneca retires MedImmune brand; Jallal leaves for new company,American City Business Journals
Feb-14-19,"Ironwood (IRWD) Q4 Earnings &amp; Revenues Beat, Shares Rise",Zacks
Feb-14-19,BMY vs. AZN: Which Stock Is the Better Value Option?,Zacks
Feb-14-19,"Tanabe Research Labs Announce FDA Acceptance of its IND Application for TR1801-ADC (MT-8633), an ADC Targeting cMet Positive Solid Tumors",PR Newswire
Feb-14-19,"AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales",Zacks
Feb-14-19,[$$] AstraZeneca Turns a Corner After a Decade of Struggles,The Wall Street Journal
Feb-15-19,Strength Seen in AstraZeneca (AZN): Stock Soars 9.3%,Zacks
Feb-19-19,2 Pharma Stocks in the Middle of an Oncology Sales Explosion,Motley Fool
Feb-19-19,Merck's (MRK) Stock Up Almost 50% in a Year: Here's Why,Zacks
Feb-25-19,Drugmakers CEOs set to get grilled at Senate hearing on rising drug prices,MarketWatch
Feb-25-19,AstraZeneca's Brilinta Found To Alleviate Cardiovascular Risk In Late-Stage Study,Benzinga
Feb-25-19,BRILINTAs Phase III THEMIS Trial Met Primary Endpoint in Patients with Established Coronary Artery Disease and Type-2 Diabetes,Business Wire
Feb-26-19,Congress Grills Drugmakers: 5 Key Takeaways,Motley Fool
Feb-26-19,Drugmakers CEOs clash with senators in hearing on drug price hikes,MarketWatch
Feb-26-19,Pharma execs offer Senate ideas to lower drug costs  except actually cutting prices,CNBC
Feb-26-19,Drugmakers CEOs set to get grilled at Senate hearing on rising drug prices,MarketWatch
Feb-26-19,Sen. Grassley says probe of 'secretive' drug industry pricing won't stop with drugmakers,CNBC
Feb-27-19,Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You,Motley Fool
Feb-27-19,Mallinckrodt (MNK) Rallies as Earnings Beat Estimates in Q4,Zacks
Feb-27-19,"Bayer (BAYRY) Q4 Earnings Beat Estimates, Revenues Up Y/Y",Zacks
Feb-27-19,"The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings",Benzinga
Feb-27-19,"Clovis (CLVS) Q4 Earnings Lag Estimates, Rubraca Sales Recover",Zacks
Feb-27-19,US FDA Approves Expanded FARXIGA and XIGDUO XR Labels for Use in Patients with Type 2 Diabetes and Moderate Renal Impairment,Business Wire
Feb-27-19,AstraZeneca/Merck's Lynparza Meets Endpoint in POLO Study,Zacks
Feb-28-19,Biocartis Group NV: BIOCARTIS ANNOUNCES 2018 RESULTS AND 2019 OUTLOOK,GlobeNewswire
Feb-28-19,FibroGen Inc (FGEN) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-06-19,J&amp;J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression,Zacks
Mar-07-19,"Recent Analysis Shows Veeva, Mobile TeleSystems OJSC, Jacobs Engineering Group, Perrigo Company plc, AstraZeneca, and Primoris Services Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Mar-08-19,"Pharma Stock Roundup: FDA OK's J&amp;J Antidepressant, CHMP Recommends Several Drugs",Zacks
Mar-11-19,Here's Why Seres Therapeutics Stock Soared Today,Motley Fool
Mar-11-19,Seres teams up with AstraZeneca to explore microbiome benefits in cancer treatment,American City Business Journals
Mar-11-19,Bayer Submits Application in EU for Prostate Cancer Drug,Zacks
Mar-11-19,Sanofi's Dupixent Gets FDA Priority Status for Nasal Polyps,Zacks
Mar-11-19,"The Zacks Analyst Blog Highlights: J&amp;J, Lilly, Pfizer, AstraZeneca and Merck's",Zacks
Mar-11-19,Should Value Investors Pick AstraZeneca PLC (AZN) Stock?,Zacks
Mar-11-19,AstraZeneca to Present New Cardiovascular Data on FARXIGA in Type 2 Diabetes At ACC 2019,Business Wire
Mar-12-19,BioNTech hires banks for IPO worth up to $800 million - sources,Reuters
Mar-12-19,How the UK Makes Money,Investopedia
Mar-13-19,"Inovio (INO) Misses on Q4 Earnings &amp; Revenues, Shares Down",Zacks
Mar-14-19,Here's Why Momentum Investors Will Love Astrazeneca (AZN),Zacks
Mar-14-19,Is Britain Headed for a Soft Brexit? 5 Picks,Zacks
Mar-15-19,"AVEO Pharmaceuticals (AVEO) Q4 Earnings Beat, Revenues Lag",Zacks
Mar-15-19,Merck's Keytruda Gets EU Approval for Difficult Lung Cancer,Zacks
Mar-18-19,Novartis' (NVS) Alcon Acquired PowerVision for $285 Million,Zacks
Mar-18-19,"Top Research Reports for Merck, Adobe & Broadcom",Zacks
Mar-18-19,Inovio's Early/Mid-Stage Vaccine Pipeline Exhibits Growth,Zacks
Mar-18-19,First Sub-Analyses from the DECLARE-TIMI 58 Trial Further Support the Cardiovascular Effects of FARXIGA in Type 2 Diabetes,Business Wire
Mar-18-19,AstraZeneca Up This Year on New Drugs &amp; Pipeline Progress,Zacks
Mar-19-19,"The Zacks Analyst Blog Highlights: Merck, Adobe, Broadcom, AstraZeneca and Ross Stores",Zacks
Mar-19-19,PhaseBio Stock Up on Positive Data From PB2452 Phase I Study,Zacks
Mar-19-19,Roche's Tecentriq Gets FDA Approval for Difficult Lung Cancer,Zacks
Mar-19-19,Why You Should Buy ABBV Stock for Income and Value,InvestorPlace
Mar-19-19,Large-Cap Pharmaceuticals Industry Outlook: A Recovery Ahead?,Zacks
Mar-19-19,"The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed",Benzinga
Mar-20-19,"Top Stock Reports for Las Vegas Sands, Phillips 66 & AstraZeneca",Zacks
Mar-21-19,J&J to record $700 million charge related to abandoned drug program,Reuters
Mar-21-19,J&J to record $700 mln charge related to abandoned drug program,Reuters
Mar-21-19,Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market,Zacks
Mar-21-19,"The Zacks Analyst Blog Highlights: Las Vegas Sands, Phillips 66, AstraZeneca, Hilton and AutoZone",Zacks
Mar-25-19,AstraZeneca's Forxiga Gets EC Approval for Type-I Diabetes,Zacks
Mar-25-19,EU approves AstraZeneca's drug for adjunct use in Type-1 diabetes,Reuters
Mar-25-19,EU approves AstraZeneca's drug for adjunct use in Type-1 diabetes,Reuters
Mar-26-19,Bayer &amp; JNJ Settle Numerous Xarelto Lawsuits for $775 Million,Zacks
Mar-27-19,Calithera (CALA) Initiates Phase I/II Study of Telaglenastat,Zacks
Mar-27-19,"Aldeyra's Eye Drug Meets Main Goal in Study, Shares Surge",Zacks
Mar-28-19,"European shares give up gains as banks weigh amid concerns on growth, Brexit",Reuters
Mar-28-19,AstraZeneca's Forxiga Gets Nod in Japan for Type I Diabetes,Zacks
Mar-28-19,There's a feeling of 'deep uncertainty': AstraZeneca,CNBC Videos
Mar-29-19,AVEO Pharmaceuticals (AVEO) to File NDA for Fotivda with FDA,Zacks
Mar-29-19,"Why AstraZeneca, Yeti Holdings, and CannTrust Holdings Slumped Today",Motley Fool
Mar-29-19,FTSE 100 gains as trade progress offsets latest Brexit setback,Reuters
Mar-29-19,AstraZeneca (AZN) Signs $6.9B Cancer Deal with Daiichi Sankyo,Zacks
Mar-29-19,Japan's Daiichi Strikes Cancer Therapy Deal With AstraZeneca Worth Up To $6.9B,Benzinga
Mar-29-19,AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal,Reuters
Mar-29-19,AstraZeneca in cancer deal with Daiichi Sankyo,Associated Press
Mar-29-19,AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal,Reuters
Mar-29-19,"RH Stock Tumbles, AstraZeneca Slides and 3 More Friday Morning Movers",Barrons.com
Mar-29-19,AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal,Reuters
Mar-29-19,AstraZeneca Slides on $6.9 Billion Cancer Drug Deal with Japan's Daiichi Sankyo,TheStreet.com
Mar-29-19,"Stocks to watch: AstraZeneca, Tui, H&M, Auto Trader, Jupiter, Evraz",Financial Times
Mar-29-19,Is This a Drug Deal or a Rights Offering?,Bloomberg
Mar-29-19,AstraZeneca Bets $6.9 Billion in Japan Cancer Therapy Deal,Bloomberg
Mar-29-19,Nikkei up on U.S.-China trade talk optimism; Daiichi Sankyo jumps,Reuters
Mar-29-19,AstraZeneca in $6.9bn cancer deal with Daiichi Sankyo,Financial Times
Apr-01-19,AstraZeneca's Selumetinib Gets Breakthrough Therapy Status,Zacks
Apr-01-19,The Dow Is Gaining Because Good News From China Is Good News for Stocks,Barrons.com
Apr-01-19,AstraZeneca's Rare Pediatric Genetic Disorder Drug Granted Breakthrough Therapy Designation,Benzinga
Apr-01-19,Selumetinib Granted US Breakthrough Therapy Designation in Neurofibromatosis Type 1,Business Wire
Apr-01-19,Here's what to expect from the stock market next month,Investopedia
Apr-02-19,AstraZeneca May Not Have the Cash Flow to Pull Off Its Big Expansion,Barrons.com
Apr-02-19,Merck's Keytruda Gets Nod for First-Line Lung Cancer in China,Zacks
Apr-02-19,Advaxis Up on Positive Early-Stage Immunotherapy Study Data,Zacks
Apr-02-19,"Stocks to watch: Rolls-Royce, Lyft, AstraZeneca, Fevertree, Pandora",Financial Times
Apr-02-19,Zeneca Wilmington Inc. -- Moody's changes outlook on AstraZeneca's A3 ratings to stable; affirms ratings,Moody's
Apr-03-19,Clovis Posts Data on Rubraca Study for Pancreatic Cancer,Zacks
Apr-03-19,"Daiichi Sankyo Company, Limited -- Moody's: Daiichi Sankyo's collaboration with AstraZeneca is positive for the former's oncology franchise",Moody's
Apr-04-19,"Inovio's HPV Candidate Shows Efficacy in Pilot Study, Stock Up",Zacks
Apr-05-19,Will Ironwood Suffer From Dependence on Linzess' Progress?,Zacks
Apr-05-19,"Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU",Zacks
Apr-05-19,Myriad Genetics Expands CDx Tie Up With AstraZeneca &amp; Merck,Zacks
Apr-05-19,"Investors Chronicle: Hostelworld. YouGov, AstraZeneca",Financial Times
Apr-08-19,"The Zacks Analyst Blog Highlights: Pfizer, Teva, Novartis, Merck and AstraZeneca",Zacks
Apr-08-19,Is AstraZeneca PLC's (LON:AZN) Balance Sheet A Threat To Its Future?,Simply Wall St.
Apr-09-19,PhaseBio Stock Up on Breakthrough Therapy Status for PB2452,Zacks
Apr-09-19,Inovio Earns 3rd Milestone Fee From AstraZeneca for MEDI0457,Zacks
Apr-10-19,Here's what to expect from the stock market next month,Investopedia
Apr-10-19,Is AstraZeneca Stock Worth Buying Before Earnings?,InvestorPlace
Apr-10-19,Alkermes Reports Positive Data From Schizophrenia Study,Zacks
Apr-10-19,J&amp;J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store?,Zacks
Apr-10-19,AstraZeneca/Merck's Lynparza Wins EU Nod for Breast Cancer,Zacks
Apr-12-19,"Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal",Zacks
Apr-12-19,"Dow 30 Stock Roundup: Procter &amp; Gamble Hikes Dividend, Boeing Q1 Commercial Deliveries Fall",Zacks
Apr-15-19,Clovis Stalls Mid-Stage Rubraca Study for Bladder Cancer,Zacks
Apr-15-19,London's FTSE 100 tugged down by miners; IWG lifts midcaps,Reuters
Apr-18-19,AVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why,Zacks
Apr-23-19,What's in the Cards for AstraZeneca (AZN) in Q1 Earnings?,Zacks
Apr-24-19,AstraZeneca chief claims vindication five years after Pfizer bid,Financial Times
Apr-25-19,"Bayer (BAYRY) Q1 Earnings Beat Estimates, Revenues Up Y/Y",Zacks
Apr-26-19,AstraZeneca PLC (AZN) Q1 2019 Earnings Call Transcript,Motley Fool
Apr-26-19,This Drug Giant Nearly Doubled Its Earnings  So Why Are Shares Slipping?,Investor's Business Daily
Apr-26-19,This Drug Giant Nearly Doubled Its Earnings  So Why Are Shares Slipping?,Investor's Business Daily
Apr-26-19,"AstraZeneca's (AZN) Q1 Earnings Beat, New Drugs Drive Sales",Zacks
Apr-26-19,"Sanofi (SNY) Q1 Earnings Top, Genzyme &amp; Vaccines Drive Sales",Zacks
Apr-26-19,"AstraZeneca, RBS earnings weigh on London markets",MarketWatch
Apr-26-19,Newer drugs fuel AstraZeneca quarterly sales beat,Reuters
Apr-26-19,AstraZeneca's first quarter profits jump 74%,Associated Press
Apr-26-19,Astrazeneca: 1Q Earnings Snapshot,Associated Press
Apr-26-19,AstraZeneca first-quarter sales beat estimates on cancer drugs,Reuters
Apr-26-19,AstraZeneca first-quarter sales beat estimates on cancer drugs,Reuters
Apr-26-19,AstraZeneca Cancer Drug Sales Fuel Profit Beating Estimates,Bloomberg
Apr-26-19,AstraZeneca cancer drugs drive growth in sales,Financial Times
Apr-29-19,Better Big Pharma Stock: AbbVie vs. AstraZeneca,Motley Fool
Apr-29-19,Edited Transcript of AZN.L earnings conference call or presentation 26-Apr-19 11:00am GMT,Thomson Reuters StreetEvents
Apr-29-19,Md. biotech files to go public in up to $92M offering,American City Business Journals
Apr-30-19,Health Care Stocks: Buy Them While They're Down,Kiplinger
Apr-30-19,AVEO Pharmaceuticals (AVEO) to Post Q1 Earnings: What's Up?,Zacks
Apr-30-19,Merck (MRK) Beats on Q1 Earnings &amp; Sales as Keytruda Shines,Zacks
May-01-19,Edited Transcript of AZN.L earnings conference call or presentation 26-Apr-19 11:00am GMT,Thomson Reuters StreetEvents
May-01-19,An Intrinsic Calculation For AstraZeneca PLC (LON:AZN) Suggests It's 46% Undervalued,Simply Wall St.
May-02-19,Drugmakers lobbying spending at 10-year high as Washington targets soaring prices,MarketWatch
May-02-19,Edited Transcript of AZN.L earnings conference call or presentation 26-Apr-19 11:00am GMT,Thomson Reuters StreetEvents
May-02-19,"The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data",Benzinga
May-02-19,AstraZeneca ties up with France's Transgene to develop viral immunotherapies,Reuters
